Pharmaxis Announces A$4.4m Placement
14th
Apr 21
Release Date: 14/04/2021 9:25am
Highlights:
- A$4.4m being raised in a placement to institutional investors
- A$20m pro-forma cash balance post raising
- Strengthened balance sheet to support ongoing clinical studies in myelofibrosis and skin scarring
- Issue price of A$0.08 represents a 1.3% premium to last closing price as at 12 April 2021
- New shareholder Karst Peak Capital Limited invests A$3.2m for a 8.9% holding in the Company
- Existing shareholder BVF Partners LP invests A$0.8m to maintain its holding at 19.5%
Categories: News and Media